CORD-19:4ca5d854d3f99440b507fd7dfae73c8ad6fc45d5 / 588659-588769 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/4ca5d854d3f99440b507fd7dfae73c8ad6fc45d5","sourcedb":"CORD-19","sourceid":"4ca5d854d3f99440b507fd7dfae73c8ad6fc45d5","text":"In a second approach we supplemented the 3D-CoG with defined plasma proteins to create tissue-like conditions.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T4799","span":{"begin":0,"end":110},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T4799","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T109","span":{"begin":0,"end":110},"obj":"Sentence"}],"attributes":[{"subj":"T109","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T481","span":{"begin":87,"end":93},"obj":"Body_part"}],"attributes":[{"id":"A481","pred":"uberon_id","subj":"T481","obj":"http://purl.obolibrary.org/obo/UBERON_0000479"},{"subj":"T481","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93ebec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ecd393"},{"id":"CORD-19-PD-UBERON","color":"#b993ec"}]}]}}